Pure red cell aplasia associated with expansion of CD3+ CD8+ granular lymphocytes expressing cytotoxicity against HLA-E+ cells
Kiyoshi L. Mori
Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this authorHisae Furukawa
Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this authorKeiko Hayashi
Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this authorKei-ji J. Sugimoto
Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this authorKazuo Oshimi
Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this authorKiyoshi L. Mori
Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this authorHisae Furukawa
Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this authorKeiko Hayashi
Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this authorKei-ji J. Sugimoto
Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this authorKazuo Oshimi
Department of Haematology, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this authorAbstract
Summary. T-cell granular lymphocyte-proliferative disorder (T-GLPD) is characterized by the proliferation of cytotoxic T lymphocytes, and is often associated with pure red cell aplasia (PRCA). The mechanism involved in the development of PRCA in T-GLPD is unknown. Peripheral blood mononuclear cells were isolated from 20 patients with T-GLPD. Ten patients had associated PRCA. Granular lymphocytes (GLs) of T-GLPD are positive for CD94, but not NKG2A. To clarify the functional role of CD94 in T-GLPD, we performed a cytotoxicity assay against the trophoblast cell line, BeWo, which is known to express human leucocyte antigen (HLA)-E, a natural ligand of CD94, and is deficient in other HLA class I and class II antigens. GLs isolated from T-GLPD with PRCA patients killed BeWo cells more significantly than GLs from T-GLPD without PRCA patients. Furthermore, GLs from T-GLPD with PRCA were significantly stimulated by a monoclonal antibody against CD94, whereas those of T-GLPD without PRCA were not. Taken together, HLA-E, a ligand of CD94, was suggested to stimulate CD94+ cells to kill HLA-E+ cells in T-GLPD with PRCA. GLs of T-GLPD with PRCA have a potential positive activity against HLA-E+ cells, whereas GLs from T-GLPD without PRCA do not. CD94 may play a key role in the pathogenesis of PRCA in T-GLPD.
References
- Aramburu, J., Balboa, M.A., Ramirez, A., Silva, A., Acevedo, A., Sanchez-Madrid, F., Landazuri, M.O. & Lopez-Botet, M. (1990) A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-γ/δ+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. Journal of Immunology, 144, 3238 – 3247.
- Borrego, F., Ulbrecht, M., Weiss, E.H., Coligan, J.E. & Brooks, A.G. (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. Journal of Experimental Medicine, 817, 813 – 818.
- Braud, V.M., Allan, D.S.J., O'Callaghan, C.A., Soderstorom, K., D'Andrea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H. & Lanier, L.L. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature, 391, 795 – 799.
- Carosella, E.D., Dausset, J. & Kirszenbaum, M. (1996) HLA-G revisited. Immunology Today, 17, 407 – 409.
- Casado, L.F., Granados, E., Algara, P., Navarro, F., Martinez-Frejo, M. & Lopez-Botet, M. (2001) High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T-large granular lymphocytes in asymptomatic patients. Haematologica, 86, 457 – 463.
- Chang, C., Rodriguez, A., Carretero, M., Lopez-Botet, M., Philips, J.H. & Lanier, L.L. (1995) Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. European Journal of Immunology, 25, 2433 – 2437.
- Ellis, S.A., Palmer, M.S. & McMichael, A.J. (1990) Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. Journal of Immunology, 144, 731 – 735.
- Exley, M., Porcelli, S., Furman, M., Garcia, J. & Balk, S. (1998) CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant Vα24 JαQ T cell receptor α chains. Journal of Experimental Medicine, 188, 867 – 876.
- Fisch, P., Handgretinger, R. & Schaefer, H.-E. (2000) Pure red cell aplasia. British Journal of Haematology, 111, 1010 – 1022.
- Frohn, C., Shlenke, P. & Kirchner, H. (1997) The repertoire of HLA-Cw-specific NK cell receptors CD158a/b (EB6 and GL183) in individuals with different HLA phenotype. Immunology, 92, 567 – 570.
- Haedicke, W., Ho, F.C., Chott, A., Moretta, I., Rudiger, T., Ott, G. & Muller-Hermilink, H.K. (2000) Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood, 95, 3628 – 3630.
- Handgretinger, R., Geiselhart, A., Moris, A., Grau, R., Teuffel, O., Bethge, W., Kanz, L. & Fisch, P. (1999) Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expression killer-cell inhibitory receptors. New England Journal of Medicine, 340, 278 – 284.
- Hoffman, R., Kopel, S., Hsu, S.D., Dainiak, N. & Zanjani, E.D. (1978) T cell chronic lymphocytic leukemia: presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro. Blood, 52, 255 – 260.
- Karre, K., Ljunggren, G.H., Piontek, G. & Kiessling, R. (1986) Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy. Nature, 319, 675 – 678.
-
King, A.,
Allan, S.J.D.,
Bowen, M.,
Powis, S.J.,
Joseph, S.,
Verma, S.,
Hiby, S.E.,
McMichael, A.J.,
Loke, Y.W. &
Braud, V.M. (2000) HLA-E is expressed on trophoblast and interacts with CD94/NKG2 on decidual NK cells.
European Journal of Immunology, 30, 1623
–
1631.
10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- Lanier, L.L. (1998) Follow the leader: NK cell receptor classical and non-classical MHC class I. Cell, 92, 705 – 707.
- Lanier, L.L., Corliss, B.C., Wu, J., Leong, C. & Phillips, J.H. (1998) Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature, 391, 703 – 707.
- Lee, N., Goodlett, D.E., Ishitani, A., Marquardt, H. & Geraghty, D.E. (1998) HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. Journal of Immunology, 160, 4951 – 4960.
- Long, E.O. (1999) Regulation of immune responses through inhibitory receptors. Annual Review of Immunology, 17, 875 – 904.
- Masmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55 – 63.
- Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M.C. & Moretta, L. (1997) Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunological Review, 155, 105 – 107.
- Mori, K.L., Egashira, M. & Oshimi, K. (2001) Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis. British Journal of Haematology, 115, 225 – 228.
- Oshimi, K. (1996) Lymphoproliferative disorders of natural killer cells. International Journal of Hematology, 63, 279 – 290.
- Oshimi, K., Yamada, O., Kaneko, T., Nishinarita, S., Iizuka, Y., Urabe, A., Inamori, T., Asano, S., Takahashi, S., Hattori, M., Naohara, T., Ohira, Y., Togawa, A., Masuda, Y., Okubo, Y., Furukawa, S., Sakamoto, S., Omine, M., Mori, M., Tatsumi, E. & Mizoguchi, H. (1993) Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia, 7, 782 – 788.
- Pazmany, L., Mandelboim, O., Vales-Gomez, M., Davis, D.M., Reyburn, H.T. & Strominger, J.L. (1996) Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science, 274, 792 – 795.
- Perez-Villar, J.J., Carretero, M., Navarro, F., Melero, I., Rodriguez, A., Bottino, C., Moretta, A. & Lopez-Botet, M. (1996) Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. Journal of Immunology, 157, 5367 – 5374.
- Ryan, J.C., Naper, C., Hayashi, S. & Daws, M.R. (2001) Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells. Immunological Review, 181, 126 – 135.
- Semenzat, G., Zambello, R., Starkebaum, G., Oshimi, K. & Loughran, Jr, T.P. (1997) The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood, 89, 256 – 260.
- Spits, H., Blom, B., Jaleco, A.C., Weijer, K., Verschuren, M.C., Van Donge, J.J., Heemskerk, M.H. & Res, P.C. (1998) Early stages in the development of human T, natural killer and thymic dendritic cells. Immunological Review, 165, 75 – 86.
- Tefferi, A. (1996) Chronic natural killer cell lymphocytosis. Leukemia and Lymphoma, 20, 245 – 248.
- Ugolini, S. & Vivier, E. (2000) Regulation of T cell function by NK cell receptors for classical MHC class I molecules. Current Opinions in Immunology, 12, 295 – 300.
- Voss, S.D., Daley, J., Ritz, J. & Robertson, M.J. (1998) Participation of the CD94 receptor complex in costimulation of human natural killer cells. Journal of Immunology, 160, 1618 – 1626.